Towards Healthcare
Cell Cycle Analysis Market Size Hits USD 24.99 Billion in 2025

Cell Cycle Analysis Market Forecast 2025 to 2034 Flow Cytometry Dominates, APAC Booms

Based on market forecasts, the global cell cycle analysis market, projected at USD 22.51 billion in 2024, is expected to reach USD 63.94 billion by 2034, growing at a CAGR of 11.02% over the forecast period. The cell cycle analysis market is expanding due to growing innovations in flow cytometry as well as rising advances in genetic research. North America led the market due to the presence of robust industries.

  • Insight Code: 5853
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

The cell cycle analysis market is projected to reach USD 63.94 billion by 2034, growing at a CAGR of 11.02% from 2024 to 2034.

North America is currently leading the cell cycle analysis market due to the robust industries.

The cell cycle analysis market includes 6 segments such as by product type, by technology, by cell type, by application, by end-user, and by region. 

Some key players include BD Biosciences, Thermo Fisher Scientific, Merck KGaA, and Agilent Technologies.

Key trends include growth in the innovation of personalized oncology and CAR-T cell therapies.

To understand the nature of diseases, the use of cell cycle analysis is increasing.

Growing innovations in flow cytometry are the factor that drives the market.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.